|
Volumn 38, Issue 10, 1999, Pages 911-912
|
Targeted therapies in rheumatoid arthritis: The need for action
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRHEUMATIC AGENT;
ETANERCEPT;
INFLIXIMAB;
UNCLASSIFIED DRUG;
AUTOIMMUNITY;
DRUG APPROVAL;
DRUG COST;
EDITORIAL;
HEALTH CARE COST;
HUMAN;
LIFE EXPECTANCY;
MORBIDITY;
MORTALITY;
PATHOGENESIS;
PATIENT SELECTION;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
UNITED KINGDOM;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DRUG THERAPY;
HUMANS;
|
EID: 0032701832
PISSN: 14620324
EISSN: None
Source Type: Journal
DOI: 10.1093/rheumatology/38.10.911 Document Type: Editorial |
Times cited : (9)
|
References (0)
|